Browse Related Topics For:

Generic Drugs

558
Pharmaceutical Industry
353
Patents
337
Pharmaceutical Patents
336
Prescription Drugs
276
Patent Infringement
259
FDA
253
ANDA
249
Patent Litigation
210
Hatch-Waxman
84
SCOTUS
82
FTC
75
Biosimilars
75
Patent-in-Suit
67
Reverse Payment Settlement Agreements
62
Pay-For-Delay
61
Actavis Inc.
61
FTC v Actavis
55
Intellectual Property Protection
55
Preemption
54
Teva Pharmaceuticals
52
Mylan Pharmaceuticals
47
Antitrust Litigation
45
Popular
44
Manufacturers
38
Appeals
38
Drug Pricing
37
BPCIA
34
FDA Approval
33
FDCA
32
Apotex
32
Medical Devices
31
Labeling
31
Sandoz
29
Healthcare
28
Failure To Warn
27
Biologics
26
AstraZeneca
25
DOJ
25
Inter Partes Review (IPR) Proceeding
24
Prior Art
23
Amgen
23
EU
23
Sherman Act
23
Watson Pharmaceuticals
22
Merck
21
Anti-Competitive
21
Antitrust Violations
21
Medicaid
21
Novartis
20
Affordable Care Act
20
Class Action
20
Obviousness
20
Patent Trial and Appeal Board
20
Warning Labels
19
Biotechnology
19
Commercial Marketing
19
Medicare
19
Settlement
18
Design Defects
18
Patent Invalidity
18
Preliminary Injunctions
18
Sandoz v Amgen
18
USPTO
17
Bayer
17
Eli Lilly
17
HHS
17
Patent Applications
17
Product Hopping
16
Antitrust Provisions
16
Infringement
16
Innovator Liability
16
Mutual Pharmaceuticals v Bartlett
16
Orange Book
16
Patent Dance
16
Pharmacies
16
PLIVA v Mensing
15
Canada
15
Declaratory Judgments
15
Summary Judgment
14
America Invents Act
14
Corporate Counsel
14
Hospira
14
OIG
13
Life Sciences
13
Notice Requirements
13
Personal Jurisdiction
13
Safe Harbors
12
Cephalon
12
CMS
12
GlaxoSmithKline
12
Pfizer
12
Rule-of-Reason Analysis
11
CA Supreme Court
11
China
11
Competition
11
Dismissals
11
False Claims Act (FCA)
11
On-Sale Bar
11
Product Exclusivity
11
Trump Administration
10
Endo Pharmaceuticals
10
Enforcement Actions
10
Health Care Providers
10
Jurisdiction
10
Trademarks
10
Warner Chilcott
9
Allergan Inc
9
Hedge Funds
9
Hospitals
9
Monopolization
9
Otsuka Pharmaceutical
9
Price-Fixing
9
Product Labels
9
Rebates
9
Reverse Payments
8
Antitrust Division
8
Attorney Generals
8
Gilead Sciences
8
Orphan Drugs
8
Par Pharmaceutical
8
Proposed Legislation
8
REMS
8
Roxane Laboratories
8
Wyeth
7
Antitrust Investigations
7
Federal Budget
7
Janssen Pharmaceuticals
7
Motion to Dismiss
7
New Legislation
7
Nexium
7
No-AG Agreement
7
Noninfringement
7
Product Defects
7
Proposed Regulation
7
RanBaxy
7
Reversal
7
Settlement Agreements
7
Suppliers
7
Takeda Pharmaceuticals
7
UK
6
AbbVie
6
aBLA
6
Abuse of Process
6
Anti-Kickback Statute
6
Brand
6
Civil Monetary Penalty
6
Claim Construction
6
Comment Period
6
Competition Authorities
6
Congressional Investigations & Hearings
6
Draft Guidance
6
Drug Safety
6
European Commission
6
Exclusivity
6
Exports
6
Government Investigations
6
Innovation
6
Italy
6
Jazz Pharmaceuticals
6
Legislative Agendas
6
Medicare Part B
6
Mensing
6
Misrepresentation
6
Off-Label Promotion
6
Post-Grant Review
6
Putative Class Actions
6
Section 340B
6
Standing
5
Biologics Price Competition and Innovation Act of 2009
5
Cartels
5
Causation
5
Cipro
5
Class Certification
5
Compliance
5
Forest Laboratories
5
GDUFA
5
Intellectual Property Litigation
5
Martin Shkreli
5
Medicare Part D
5
Mexico
5
Opioid
5
Patent Term Extensions
5
Patent-Eligible Subject Matter
5
Pending Legislation
5
Pleading Standards
5
PMNOC Regulations
5
Professional Conferences
5
SEC
5
UK Competition and Markets Authority (CMA)
5
Unfair Competition
5
User Fees
4
Abbott Laboratories
4
Allergan v Sandoz
4
Amarin
4
Anticompetitive Agreements
4
Aurobindo Pharmaceuticals
4
Australia
4
Biopharmaceutical
4
Boehringer
4
Burden of Proof
4
Cancer
4
Cartwright Act
4
CETA
4
Citizen Petitions
4
Classen Immunotherapies
4
DaimlerAG
4
Data Protection
4
Disgorgement
4
Doctrine of Equivalents
4
Drug Approvals
4
Duty to Deal
4
Federal Rule 12(b)(6)
4
First Amendment
4
Forum Shopping
4
Genentech
4
Health Canada
4
Health Insurance
4
Imports
4
Induced Infringement
4
Johnson & Johnson
4
Kickbacks
4
Marketing
4
Medicare Modernization Act
4
Mental Health
4
Multidistrict Litigation
4
Off-Label Use
4
OPPS
4
Permanent Injunctions
4
Physicians
4
Prescription Drug Coverage
4
Qui Tam
4
Real Party in Interest
4
Research and Development
4
Spectrum
4
Subpoenas
4
TFEU
4
Third-Party Relationships
4
Trans-Pacific Partnership
3
21st Century Cures Initiative
3
Abuse of Dominance
3
Acquisitions
3
Antitrust Conspiracies
3
Arbitration
3
Clinical Trials
3
Congressional Committees
3
Cost-Sharing
3
Criminal Antitrust Litigation
3
DaimlerChrysler v Bauman
3
Damages
3
De Novo Standard of Review
3
Debt Ceiling
3
Direct Purchasers
3
Elan Pharmaceuticals
3
Estoppel
3
False Advertising
3
FCPA
3
FDARA
3
First Sale Doctrine
3
France
3
French Competition Authority
3
Fresenius
3
FTC Act
3
General Jurisdiction
3
Generic
3
Google
3
Health Information Technologies
3
Healthcare Reform
3
Hoffman LaRoche
3
Injunctions
3
Injunctive Relief
3
Innovation Act
3
IP License
3
Joinder
3
Laches
3
Learned Intermediary
3
Licenses
3
Licensing Rules
3
Manufacturing Defects
3
Medical Research
3
Mergers
3
Minimum Contacts
3
Motion for Sanctions
3
NIH
3
Obama Administration
3
OxyContin
3
Patent Prosecution
3
Patent Term Adjustment
3
Physician Fee Schedule
3
Price Gouging
3
Public Health
3
Public Health Service Act
3
Retailers
3
RICO
3
Risk Mitigation
3
Rule 23
3
Rulemaking Process
3
Rural Areas
3
Sanofi
3
Sequestration
3
Shire Development v Watson
3
SmithKline Beecham
3
Specific Jurisdiction
3
Supplementary Protection Certificate
3
Supreme Court of Canada
3
Telehealth
3
Trade Agreements
3
Transfer of Venue
3
Twombly/Iqbal Pleading Standard
3
Unjust Enrichment
3
Vacated
3
Whistleblowers
3
Wholesale
2
Actos
2
Administrative Proceedings
2
Advertising
2
Ambulatory Surgery Centers
2
Amended Regulation
2
Anticompetitive Behavior
2
Antitrust Injuries
2
Automatic Enrollment
2
Automotive Industry
2
Barack Obama
2
Brand Name Prescription Drugs
2
Breach of Warranty
2
Bribery
2
Burden-Shifting
2
Cadillac Tax
2
CADTH
2
CAFC
2
Calculation of Damages
2
CDC
2
Center for Drug Evaluation and Research (CDER)
2
Chevron Deference
2
CHIP
2
Co-Op
2
Consent Order
2
Contraceptive Coverage Mandate
2
Copyright
2
Copyright Infringement
2
Corruption
2
Covered Business Method Patents
2
Dairy Farmers
2
Declaratory Relief
2
Direct Infringement
2
Disclosure
2
Discovery
2
Divestiture
2
Double Patent
2
Drug Compounding
2
Durable Medical Equipment
2
Duty to Warn
2
E-Cigarettes
2
En Banc Review
2
Evidence
2
Excessive Pricing
2
Expert Testimony
2
Failure To State A Claim
2
FDA Commissioner
2
FDA Reauthorization Act
2
FDASIA
2
Federal Aviation Administration (FAA)
2
Federal Question Jurisdiction
2
Final Rules
2
Financial Institutions
2
Food and Drug Administration Amendments Act (FDAAA)
2
Food Safety
2
Foreign Manufacturers
2
FQHC
2
Fraud
2
Free Speech
2
Governor Cuomo
2
Healthcare Costs
2
India
2
Inspections
2
Interlocutory Injunctions
2
International Arbitration
2
International Harmonization
2
INTERPOL
2
Inventions
2
Inventors
2
JAMA
2
Japan
2
John Boehner
2
Joint Venture
2
Jury Verdicts
2
Kmart
2
Lanham Act
2
Leave to Appeal
2
License Agreements
2
Medicare Prescription Drug Improvement and Modernization Act (MMA)
2
MedPAC
2
Medtronic
2
Method Claims
2
Motion for Reconsideration
2
Motion To Stay
2
Multinationals
2
Native American Issues
2
Negligence
2
New Guidance
2
Non-Compete Agreements
2
Numerosity
2
Nursing Homes
2
Octane Fitness v. ICON
2
Offsets
2
Out-of-State Companies
2
PATENT Act
2
Patent Owner Preliminary Response
2
Patent Reform
2
Patent Validity
2
Patented Medicine Prices Review Board (PMPRB)
2
Patented Medicines
2
Patients
2
PDUFA
2
Pediatrics
2
Petition for Writ of Certiorari
2
Pharmacist
2
PHRMA
2
Physician Medicare Reimbursements
2
Predominance Requirement
2
Presidential Elections
2
Presumption of Validity
2
Prilosec
2
Private Right of Action
2
Profits
2
Proposed Amendments
2
Public Disclosure
2
Public Meetings
2
Recordkeeping Requirements
2
Regulatory Agenda
2
Regulatory Oversight
2
Reimbursements
2
Remuneration
2
Reporting Requirements
2
Risk Assessment
2
Sanofi-Aventis
2
Schering-Plough
2
Sham Litigation Exception
2
SNDAs
2
Software
2
Standard of Review
2
State Law Tort Claims
2
Stocks
2
Strategic Enforcement Plan
2
STRONG Patents Act
2
Subject Matter Jurisdiction
2
Substance Abuse
2
Supply Chain
2
Surveys
2
Tariffs
2
Telemedicine
2
Teva v Sandoz
2
Textiles
2
The Clayton Act
2
Trade Relations
2
Trademark Registration
2
TRIPS Agreement
2
TRO
2
Uniform Commercial Code (UCC)
2
Webinars
2
Websites
2
White Collar Crimes
2
WTO
2
Young Lawyers
1
35 U.S.C. § 271(e)(1)
1
3D Printing
1
510(k) RTA
1
Acceleration
1
ACOs
1
Advance Notice
1
Affirmative Defenses
1
Aircraft
1
AL Supreme Court
1
Alien Tort Statute
1
ALJ
1
Alternative Payment Models (APM)
1
Ambiguous
1
Ambulance Providers
1
Amended Complaints
1
Amgen v Apotex
1
Amgen v Sandoz
1
Amnesty
1
AMP v Myriad
1
Andrew Cuomo
1
Anti-Bribery
1
Anti-Corruption
1
Anti-Monopoly
1
Antibiotics
1
App Developers
1
Apple
1
Apportionment
1
Article III
1
Asia Pacific
1
Assignments
1
Australian Competition and Consumer Commission
1
Auto Parts
1
Automatic Stay
1
Aviation Industry
1
Bad Debt
1
Banking Sector
1
Banks
1
Barclays
1
Bausch & Lomb
1
Best Practices
1
Bid Rigging
1
Bifurcation
1
Biogen Idec
1
Bipartisan Budget
1
Bipolar Disorder
1
Birth Defects
1
Boeing
1
Books
1
Bowman v Monsanto
1
Boycotts
1
BPCI
1
Brazil
1
Breach of Contract
1
Bristol-Myers Squibb
1
Brokers
1
BSA/AML
1
BsUFA
1
Bundled Payments
1
Cadence Pharmaceuticals Inc.
1
CAFA
1
Carve Out Provisions
1
Cease and Desist Orders
1
Celltrion
1
CEOs
1
Certificates of Supplementary Protection (CSPs)
1
CFDA
1
Charitable Organizations
1
Charitable PAPs
1
Cisco v CommilUSA
1
Citron Pharmaceuticals
1
CJEU
1
Class Members
1
Classification
1
Clear and Convincing Evidence
1
Clearance
1
CLIA
1
Co-payments
1
Collateral Estoppel
1
Color Marks
1
Comcast v. Behrend
1
Community Trademark
1
Compensation
1
Competition Act
1
Complex Litigation
1
Confidential Information
1
Confidentiality Agreements
1
Conflicting Proposals
1
Congressional Budget Office
1
Constitutional Challenges
1
Consultation Periods
1
Consumer Fraud
1
Consumer Product Safety Commission (CPSC)
1
Contingency Fees
1
Continuing Legal Education
1
Contraceptives
1
Copyright Litigation
1
Corporate Executives
1
Corrective Actions
1
Counterclaims
1
Counterfeit Drugs
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Proceedings
1
Credit Suisse
1
Criminal Prosecution
1
Customer-Loyalty Programs
1
CVS
1
Cybersecurity
1
Daiichi Sankyo
1
Data Breach
1
Data Collection
1
DE Supreme Court
1
Decriminalization of Marijuana
1
Defect
1
Deferred Prosecution Agreements
1
Deficit Reduction
1
Delaware General Corporation Law
1
Delay Claims
1
Denial of Certiorari
1
Department of Veterans Affairs
1
Design Patent
1
Designer Professionals' Liability
1
Device Classification
1
DHS
1
Diagnostic Imaging Services
1
Diagnostic Tests
1
Dietary Supplements
1
Direct Marketing Association
1
Directed Verdicts
1
Disclosure Requirements
1
Discovery Disputes
1
Discovery Rule
1
Dismissal With Prejudice
1
Disparagement
1
Dispute Resolution
1
Distributors
1
Diversity Jurisdiction
1
Divided Infringement
1
Divisional Applications
1
DMCA
1
DOHA
1
DOL
1
DQSA
1
Drug & Alcohol Abuse
1
Drug Design
1
Drug Distribution
1
Drug Wholesaling
1
Duty of Care
1
Duty to Update
1
EAR
1
Edith Ramirez
1
EHR
1
Elder Issues
1
Electronic Filing
1
Email
1
Emerging Markets
1
Employer Mandates
1
Energy Sector
1
Enforcement
1
Entertainment Industry
1
EPA
1
European Court of Justice (ECJ)
1
European Medicines Agency (EMA)
1
European Patent Office
1
Evidence Suppression
1
Exceptional Case
1
Exceptions
1
Exclusive Licenses
1
Exclusive Remedy
1
Executive Orders
1
Export Controls
1
Extraterritoriality Rules
1
Facebook
1
Fair Use
1
False Evidence
1
False Statements
1
FBI
1
FD&C Act
1
Federal Jurisdiction
1
Federal Register
1
Federal Rule 12(b)(1)
1
Federal Rules of Civil Procedure
1
Fee-for-Service
1
FERA
1
FFDCA
1
Filing Fees
1
Financial Crisis
1
Financial Instruments
1
Financial Markets
1
Fines
1
Food & Drug Regulations
1
Food Contamination
1
Food Labeling
1
Food Recalls
1
Foreign Corporations
1
Foreign Exchanges
1
Foreign Investment
1
Foreign Trade Regulations
1
Foreseeability
1
Form 8-K
1
Forum
1
Forum Non Conveniens
1
Forum Selection
1
FRAND
1
Fraud and Abuse
1
Fraudulent Concealment
1
Fraudulent Inducement
1
Fraudulent Procurement
1
FRCP 23(b)(3)
1
FTEs
1
GAO
1
General Court of the European Union (GCEU)
1
Genetically Engineered Seed
1
Genzyme
1
Germany
1
Global Standards
1
Good Clinical Practices
1
Goodyear
1
Governor Brown
1
Grable Factors
1
Grand Juries
1
Grocery Stores
1
Guilty Pleas
1
Gun-Jumping
1
Hart-Scott-Rodino Act
1
Hazardous Waste
1
Health Safety
1
Healthcare Facilities
1
Healthcare Fraud
1
Hearsay
1
HEAT
1
HELP
1
Hepatitis C
1
Highmark
1
Highmark v. Allcare
1
Hillary Clinton
1
HIPAA
1
Home Health Care
1
Honeywell International
1
Hospital Mergers
1
Hotels
1
HRSA
1
Human Genes
1
ICD-10
1
ICSID
1
Imminent Harm
1
Implied Preemption
1
Income Taxes
1
Indirect Purchasers
1
Inducements
1
Inflation Adjustments
1
Information Disclosure Statement
1
Information Reports
1
Information Sharing
1
Informed Consent
1
Inspector General
1
Insurance Industry
1
Intent-to-Use
1
Interest Rates
1
Interlocutory Appeals
1
International Treaties
1
Investigational New Drug Application (IND)
1
Investment
1
Investment Management
1
Investors
1
IPAB
1
IRF Claim Processing
1
Irreparable Harm
1
IRS
1
Issue Preclusion
1
ITC
1
Judges
1
Judgment on the Pleadings
1
Judicial Review
1
Jury Awards
1
Justiciable Controversy
1
King v Burwell
1
Kirtsaeng v. John Wiley & Sons
1
Leave to Amend
1
Legislative Riders
1
Lenz v Universal Music Corp.
1
LG Electronics
1
Libor
1
Likelihood of Success
1
Limelight v Akamai
1
Lipitor
1
Long Term Care Facilities
1
Loss Causation
1
Low-Income Issues
1
MACs
1
Mandamus Petitions
1
Market Manipulation
1
Marketing Authorization Application
1
Marketing Exclusivity Periods
1
Material Defects
1
Material Misrepresentation
1
Materiality
1
Mayne Pharmaceuticals
1
Media
1
Medical Device User Fee Program (MDUFA IV)
1
Medical Foods
1
Medical Marijuana
1
Medicare Advantage
1
Medicare Advantage Organizations (MAOs)
1
Member State
1
Merger Controls
1
Microsoft
1
Ministry of Health
1
Mistrial
1
Monsanto
1
Mootness
1
Motion for Summary Judgment
1
Motion To Centralize
1
Motion to Compel
1
Motorola
1
Mylan Pharmaceuticals Inc v Acorda Theraputics Inc
1
Myriad
1
NAFTA
1
National Evaluation System for Health Technology (NEST)
1
National Security
1
Negligent Design
1
Negotiations
1
New Regulations
1
New Trial
1
Nexus
1
Nike
1
NJ Supreme Court
1
Nominations
1
Non-Grandfathered Health Plans
1
Non-Prosecution Agreements
1
Notice of Intent
1
Notifications
1
Nutritional Supplements
1
OCR
1
OFAC
1
Office Depot
1
Office of Regulatory Affairs (ORA)
1
Omissions
1
Omnicare
1
Online Drug Sales
1
Open Enrollment
1
OTC
1
OTDP
1
Out-of-State Judgments
1
Over-the-Counter Sales
1
PACE
1
Pain Management Clinics
1
Panasonic
1
Parallel Claims
1
Patent Assertion Entities
1
Patent Exhaustion
1
Patent Expiration
1
Patent Filings
1
Patent Terms
1
Patent Trolls
1
Patent-Misuse
1
Patentability Search
1
Patient Assistance Programs
1
Patient Self-Referral
1
Pay-to-Delay System
1
Pharmaceutical Benefits Scheme
1
Pharmaceutical Distribution
1
Pharmaceutical Reverse Distributors
1
PHSA
1
Physician Payments
1
Political Campaigns
1
Political Candidates
1
Post-Market Approval
1
Pretext
1
Price Manipulation
1
Price Transparency
1
Prince
1
Proctor & Gamble
1
Procurement Guidelines
1
Prometheus
1
Promotional Items
1
Proposed Rules
1
Public Consultations
1
Public Domain
1
Public Hearing
1
Public Performance Rights
1
Public Policy
1
Public Procurement Policies
1
Public Transportation
1
Public Use
1
Purchase Agreement
1
Rare Earth Metals
1
Reaffirmation
1
Reauthorization
1
Registration
1
Registration Requirement
1
Regulatory Standards
1
Reissue Patents
1
Relators
1
Remedies
1
Renewal Fees
1
Repeal
1
Res Ipsa Loquitur
1
Restraining Orders
1
Restraint of Trade
1
Risk Management
1
RMBS
1
ROI
1
Rule 11
1
Rules of Civil Procedure
1
Rupert Murdoch
1
Rural Health Care Program
1
Safety Precautions
1
Sales Contracts
1
SAMHSA
1
Samsung
1
SCA Hygiene Products Aktiebolag v First Quality Baby Products
1
Section 2
1
Section 8
1
Securities
1
Securities Fraud
1
Senate Judiciary Committee
1
Set-Asides
1
SFDA
1
Sham Citizen Petitions
1
Shell Oil
1
Skilled Nursing Facility
1
Social Security
1
Solar Energy
1
Solar Panels
1
Solicitor General
1
South Africa
1
Spain
1
Spoliation
1
Sponsors
1
Sports
1
Standard Essential Patents
1
Standard of Proof
1
Standing Objections
1
Staples
1
State Health Insurance Exchanges
1
State Law Claims
1
State of Incorporation
1
Stem cells
1
Stock Drop Litigation
1
Structured Financial Products
1
Subsidies
1
Supply Agreements
1
Surveillance
1
Takedown Notices
1
Tax Credits
1
TC Heartland LLC v Kraft Foods
1
Teamsters
1
Technology Transfer Agreements
1
Television Service Providers
1
Textbooks
1
The Patent Act
1
Tobacco Regulations
1
Tolling
1
Tortious Interference
1
Toshiba
1
Trade Policy
1
Trade Promotion Authority
1
Trade Secrets
1
Trademark Application
1
Trademark Searches
1
Transfer of Title
1
Transparency
1
Transvaginal Mesh
1
Trials
1
TRICARE
1
Twentieth Century Fox
1
Two-Midnight Rule
1
Tyco
1
U.S. Treasury
1
Unfair Pricing
1
Unitary Patent
1
Universal Health Services Inc v United States ex rel Escobar
1
Utility Patents
1
Vaccinations
1
Valeant
1
Veterans
1
Veterans Administration
1
Veterinary Products
1
Viagra
1
Walker Process Claims
1
Warranties
1
Wells Fargo
1
Willful Infringement
1
WIPO
1
Wireless Devices
1
Women's Preventable Healthcare Mandates
1
Work Plans
1
Workers' Compensation Claim
1
World Intellectual Property Organisation
1
Written Notice
1
Wrongful Death
1
Yahoo!
1
YouTube
1
Zofran